internal
Brian S. Tyler
Chief Executive Officer
Executive
7 yr
10 reports
McKesson Corporation ·MCK
Four operating presidents run distinct P&Ls under the CEO
Healthcare · Fortune #9 · Divisional structure · 51K employees · Irving, TX
View as of:
10
CEO span
near peer avg (10)
10
Avg span
wide
2
Max depth
2 levels
3.9 yr
Avg tenure
stable vs FY2024
10%
Internal hires
↓ below industry avg
Consolidated financials FY2025 · period end 2025-03-31 · 10-K
Revenue
$359.1B
Operating income
$4.4B
Net income
$3.3B
Total assets
$75.1B
Shares out
125M
Sourced from McKesson Corporation DEF 14A · filed 2025-06-20 ↗ View on SEC
Interactive org chart
McKesson Corporation organizational chart
Explore the executive structure, reporting layers, and scenario-ready operating model from public filings.
Open editable chart
Take this model into your AI workspace Use AI to reason through the model, then bring the scenario back into Creately Atlas.
Choose a prompt, then open an AI app and paste.
Download the CSV data instead
Four operating presidents run distinct P&Ls under the CEO. This page maps McKesson’s divisional leadership structure, highlights the executive team, analyzes reporting spans, and compares McKesson’s model with key healthcare distribution peers.
What to model
Use the chart to test org decisions, not just view reporting lines
Start with the public baseline, then use the scenario views and source-backed changes to ask what happens when leadership, span, or team ownership shifts.
Latest signal Kenny K. Cheung joined as Executive Vice President and Chief Financial Officer
Appointed CFO effective May 29, 2026, joining from Sysco Corporation.
Source · See change logScenario views in the chart
- Add a Chief Operating Officer Introduce a COO to consolidate oversight of the four operating presidents and reduce CEO span.
- Spin off Medical-Surgical Solutions Remove the Medical-Surgical segment to sharpen focus on pharmaceutical and technology platforms.
Atlas work this supports
- Connect Workday or UKG Get these analytics for YOUR org — tenure, span of control, headcount, automatically from your HRIS.
- Connect Salesforce Map your target accounts like this. Import contacts, visualize decision chains, plan multi-threading.
- Plan a Reorg Use this as a starting point. Model scenarios, compare structures, present options to your board.
The people
Who's running this
11 executives identified as Named Executive Officers in the most recent SEC proxy. Bar length scales with tenure.
Kenny K. Cheung
Executive Vice President and Chief Financial Officer
Finance
1 yr
0 reports
Joan Eliasek
President, North American Pharmaceutical Distribution
U.S. Pharmaceutical
3 yr
0 reports
Kirk Kaminsky
Executive Vice President, Group President, North American Pharmaceutical Services
Pharma Services
5 yr
0 reports
Kevin Kettler
Executive Vice President, President, Prescription Technology Solutions
RxTS
4 yr
0 reports
Stanton McComb
President, Medical-Surgical
Medical-Surgical Solutions
6 yr
0 reports
Francisco Fraga
Executive Vice President, Chief Information Officer and Chief Technology Officer
Technology
2 yr
0 reports
Michele Lau
Executive Vice President and Chief Legal Officer
Legal
2 yr
0 reports
LeAnn B. Smith
Executive Vice President and Chief Human Resources Officer
Human Resources
5 yr
0 reports
Thomas L. Rodgers
Executive Vice President and Chief Strategy and Business Development Officer
Strategy
6 yr
0 reports
Nimesh Jhaveri
Executive Vice President and Chief Impact Officer
Impact & Sustainability
3 yr
0 reports
The pay
Executive compensation
From the most recent DEF 14A Summary Compensation Table. 1 named executive officers disclosed. Bar length scales with total compensation.
Brian S. Tyler $20.2M
- Base salary
- $1.54M
- Stock awards
- $14.50M
- Non-equity incentive
- $3.67M
- Other
- $450K
- Fiscal year
- FY2025
- Source
- SEC DEF 14A ↗
The businesses
How McKesson Corporation divides the work
3 divisions report into the group CEO. Tile size scales with estimated headcount.
U.S. Pharmaceutical
30K employees
President, North American Pharmaceutical Distribution (Joan Eliasek)
Largest segment distributing branded, generic, and specialty drugs across the U.S.
$327.7B rev $4.0B op inc 1.22% margin +17.6% YoY FY2025
Prescription Technology Solutions
4K employees
President, Prescription Technology Solutions (Kevin Kettler)
Technology and services focused on medication access, affordability, and adherence.
$5.2B rev $875M op inc 16.8% margin +9.4% YoY FY2025
Medical-Surgical Solutions
7K employees
President, Medical-Surgical (Stanton McComb)
Distribution of medical-surgical supplies and private-label products.
$11.4B rev $773M op inc 6.8% margin +0.6% YoY FY2025
The thesis
Why this org is unusual
McKesson’s most distinctive structural feature is that four large operating businesses each have a president reporting directly to the CEO.
The org chart shows U.S. Pharmaceutical Distribution, North American Pharmaceutical Services, Prescription Technology Solutions, and Medical‑Surgical Solutions all led as quasi‑independent P&Ls.
This divisional setup concentrates operational accountability at the CEO level while keeping corporate functions lean. Finance, Legal, HR, Technology, Strategy, and Impact are centralized, supporting the operating presidents rather than owning P&Ls themselves.
The structure aligns closely with McKesson’s segment reporting in the 10‑K, reinforcing disciplined capital allocation and performance management by business line rather than geography or function.
- No COO role
- Four operating presidents with P&L control
The comparison
How McKesson Corporation stacks up
Compared with peers like Cardinal Health and Cencora, McKesson pushes more operational authority to business presidents rather than consolidating under a COO. Cardinal Health relies more heavily on a COO‑style integrator, while Cencora is more functionally centralized. McKesson’s absence of a COO and its reliance on …
C-suite size
Reporting depth
McKesson Corporation
2 levels
4 levels
4 levels
5 levels
5 levels
Avg C-suite tenure
Has COO / Has CAIO
McKesson Corporation — no COO — no CAIO
Current signals
What changed recently
McKesson announced a planned CFO transition, with Kenny Cheung succeeding long‑time CFO Britt Vitalone in May 2026.
- newKenny K. Cheung Executive Vice President and Chief Financial Officer
Appointed CFO effective May 29, 2026, joining from Sysco Corporation.
Source - departedBritt J. Vitalone Executive Vice President and Chief Financial Officer
Announced retirement effective May 28, 2026; to serve as advisor starting July 2026.
Source
Leadership Timeline
Year-over-year executive structure based on SEC proxy and annual filings.
FY2025
DEF 14A filed 2025-06-20
- CEO
- Brian S. Tyler
- CEO span
- 9
- C-suite
- 5
- Avg tenure
- 4.2 yr
Leadership centered on long‑tenured CEO with stable functional team.
Named executive officers (5)
- Brian S. Tyler - Chief Executive Officer since 2019
- Britt J. Vitalone - Chief Financial Officer since 2020
- Michele Lau - Chief Legal Officer since 2024
- LeAnn B. Smith - Chief Human Resources Officer since 2021
- Thomas L. Rodgers - Chief Strategy and Business Development Officer since 2020
FY2024
DEF 14A filed 2024-06-21
- CEO
- Brian S. Tyler
- CEO span
- 9
- C-suite
- 5
- Avg tenure
- 4.5 yr
Board refreshed legal and technology leadership.
Named executive officers (5)
- Brian S. Tyler - Chief Executive Officer since 2019
- Britt J. Vitalone - Chief Financial Officer since 2020
- Michele Lau - Chief Legal Officer since 2024
- LeAnn B. Smith - Chief Human Resources Officer since 2021
- Thomas L. Rodgers - Chief Strategy and Business Development Officer since 2020
FY2023
DEF 14A filed 2023-06-23
- CEO
- Brian S. Tyler
- CEO span
- 10
- C-suite
- 6
- Avg tenure
- 5.1 yr
Broader executive slate prior to 2024–2026 transitions.
Named executive officers (1)
- Brian S. Tyler - Chief Executive Officer since 2019
Year-over-year changes
Leadership remained stable year over year with minor role refinements.
- CEO span: 9 → 9
- C-suite size: 5 → 5
- Avg tenure: 4.5 → 4.2 yr
- retitled Michele Lau - Chief Legal Officer (was General Counsel) (DEF 14A, June 20, 2025)
Frequently Asked Questions
Who is the CEO of McKesson?
Brian S. Tyler has served as Chief Executive Officer of McKesson since 2019.
What type of organizational structure does McKesson use?
McKesson uses a divisional structure organized around major operating segments.
How many direct reports does McKesson's CEO have?
The CEO has ten direct reports, including operating presidents and functional leaders.
How has McKesson's leadership changed recently?
In 2026, McKesson announced the retirement of CFO Britt Vitalone and the appointment of Kenny Cheung as his successor.
Does McKesson have a COO?
No. McKesson does not have a COO; operating presidents report directly to the CEO.
Sources
- 8-K Filing, March 5, 2026
- SEC EDGAR: McKesson Corporation DEF 14A Proxy Statement
- SEC EDGAR: McKesson Corporation 10-K Annual Report
Reference
Cite this page
If you reference this page in research, analysis, or news writing, use one of the formats below. Citation includes the SEC filing source where applicable.
APA 7th
Creately. (2026). McKesson Corporation organizational structure. Creately. Retrieved , from https://creately.com/org-chart/fortune-500/mckesson/MLA 9th
"McKesson Corporation Organizational Structure." Creately, April 1, 2026, https://creately.com/org-chart/fortune-500/mckesson/. Accessed .Chicago 17
Creately. "McKesson Corporation Organizational Structure." Last modified April 1, 2026. https://creately.com/org-chart/fortune-500/mckesson/.Original SEC source View on SEC ↗
McKesson Corporation. DEF 14A. Filed 2025-06-20. U.S. Securities and Exchange Commission. https://www.sec.gov/Archives/edgar/data/927653/000092765325000061/mck-20250620.htmPermanent URL: https://creately.com/org-chart/fortune-500/mckesson/ · last updated 2026-04-01